
Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ix...
16 Jul 23min

Author Interview: Dr Murat Torgutalp, June 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Murat Torgutalp, from the Charité – Universitätsmedizin in Berlin, as they discuss his recent paper ‘Frequency and characteri...
9 Jul 29min

Discussing RA: Infectious complications of RA treatments
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two recent studies by Etani et al. and George et ...
25 Jun 9min

Author Interview: Doctor Chung-Mao Kao, May 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication ‘Malignancy risk in patient...
23 Jun 13min

Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis. This month’s conversat...
18 Jun 13min

EULAR 2026 Review Podcast
Join Professors Xenofon Baraliakos, Laura Coates and Dr Sofia Ramiro as they break down the top RA, PsA and axSpA abstracts, sessions and posters from this year's EULAR conference.
12 Jun 39min

EULAR 2026 Day 4 Highlights Podcast
Join Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 4 of EULAR 2026 (Saturday, June 6th).
6 Jun 4min

EULAR 2026 Day 3 Highlights Podcast
Join Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 3 of EULAR 2026 (Friday, June 5th).
5 Jun 3min




















